logo_Pharmarte_1logo_Pharmartelogo_Pharmarte_1logo_Pharmarte_1
  • Home
  • Chi siamo
  • Contatti
  • Prodotti
  • Bibliografia
    • Bibliografia Inotir
    • Bibliografia Mthfr Prevent
    • Bibliografia Mthfr Prevent PLUS
    • Bibliografia Semel e Semel oro
  • Italiano
  • English
✕

Bibliografia Inotir

  • Home
  • Bibliografia
  • Bibliografia Inotir
  • Filtra per
  • Categorie
  • Tags
  • Autori
  • Mostra tutto
  • All
  • Bibliografia
  • Bibliografia Ginger Mamma
  • Bibliografia Inotir
  • Bibliografia Metra
  • Bibliografia Mthfr Prevent
  • Bibliografia Mthfr Prevent PLUS
  • Bibliografia Semel e Semel oro
  • Prodotti
  • All
  • All
  • admin
4 Agosto 2017

A scientific review: the role of chromium in insulin resistance

Diabetes Educ. 2004;Suppl:2-14. Chromium is an essential mineral that appears to have a beneficial role in the regulation of insulin action and its effects on carbohydrate, protein and lipid metabolism. Chromium is an important […]
Ti piace?
Leggi di più
4 Agosto 2017

Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis

um Reprod Update. 2010 Sep-Oct;16(5):459-66. Youssef MA1, van Wely M, Hassan MA, Al-Inany HG, Mochtar M, Khattab S, van der Veen F. Recently, dopamine agonists were proposed as a prophylactic treatment for ovarian […]
Ti piace?
Leggi di più
4 Agosto 2017

Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome

Fertil Steril. 2006 Jul;86(1):243-6. Lydic ML1, McNurlan M, Bembo S, Mitchell L, Komaroff E, Gelato M. Trivalent chromium (1000 microg), as chromium picolinate, given without change in diet or activity level, caused […]
Ti piace?
Leggi di più
4 Agosto 2017

D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.

Gynecol Endocrinol. 2011 Apr;27(4):256-62.Galazis N(1), Galazi M, Atiomo W. The pathogenesis of polycystic ovary syndrome (PCOS) has been linked to the development of insulin resistance and […]
Ti piace?
Leggi di più
4 Agosto 2017

Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.

Med Hypotheses. 2015 Jul;85(1):45-8. Brownley KA(1), Boettiger CA(2), Young L(3), Cefalu WT(4). Dietary chromium supplementation for the treatment of diabetes remains controversial. The prevailing view that […]
Ti piace?
Leggi di più
4 Agosto 2017

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction

J Hum Reprod Sci. 2010 May;3(2):85-90. Sherwal V1, Malik S, Bhatia V. Ever since ovarian hyperstimulation syndrome (OHSS) was recognized as a clinical entity, various treatment modalities have been […]
Ti piace?
Leggi di più
4 Agosto 2017

Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

Fertil Steril. 2005 Dec;84(6):1755-7. Lucidi RS1, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG. In women with polycystic ovary syndrome, chromium picolinate (200 microg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency […]
Ti piace?
Leggi di più
4 Agosto 2017

Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome.

Minerva Ginecol. 2010 Dec;62(6):525-31. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F Abstract AIM:Polycystic ovary syndrome is the most common cause of […]
Ti piace?
Leggi di più
4 Agosto 2017

Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.

Gynecol Endocrinol. 2013 Apr;29(4):375-9. Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V. Abstract OBJECTIVE: To evaluate the effects the administration of myo-inositol (MYO) on hormonal parameters in a group […]
Ti piace?
Leggi di più
Per saperne di più
Per informazioni sui nostri prodotti: Clicca qui | Ti contatteremo IN TEMPI BREVI!

logo_Pharmarte

è un’azienda farmaceutica nata nel 2006 ed impegnata nella ricerca di soluzioni terapeutiche efficaci ma prive di effetti collaterali e dannosi.

Contattaci

Email: info@pharmarte.com

Telefono: +39 068413940
Fax: +39 068541578

© Copyright 2020- PHARMARTE SRL P. IVA 07578411006 Viale Liegi 41 - Roma
    • Italiano
    • Inglese
      Richiesta informazioni: